Products - Psychosis and schizophrenia | Topic | NICE

Showing 3 products

Date | Title

New and updated: New in the last 6 monthsRemove ‘New and updated: New in the last 6 months’ filter

Abilify MyCite for treating bipolar disorder 1 or schizophrenia [ID3833]
Status:
Topic prioritisation
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Subcutaneous olanzapine for treating schizophrenia [TSID12289]
Status:
Topic prioritisation
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Severe and enduring mental illness guidance review
Status:
In development
Programme:
NICE guideline
Expected publication date:
TBC